InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Browse the complete record of transactions filed by Nagendran Sukumar, Director. Officer active across 1 companies, notably Taysha Gene Therapies, Inc.. In total, 2 filings have been published. Total volume traded: €142k. The latest transaction was disclosed on 2 February 2022 (Acquisition). Regulator: SEC (Form 4). All data is free.
Declarations2 total
€71,04910,000 shares@ €7.10490.0041% mcap100.0% of flow
Common Stock
SEC:0001209191-22-006652·
Ideal exit: 30 Oct 2022 (T+270)
€71,04910,000 shares@ €7.10490.0041% mcap50.0% of flow
Common Stock
SEC:0001209191-22-006652:0·
Ideal exit: 30 Oct 2022 (T+270)
2 of 2 declarations
About Nagendran Sukumar
Sukumar Nagendran serves as a Director at Taysha Gene Therapies, Inc. In this role, he participates in the company's strategic decisions and governance. Nagendran brings expertise in biotechnology and gene therapies, which is crucial for Taysha's innovation. His commitment to excellence and strategic vision are assets to the board.
